1 Lanini S, Ustianowski A, Pisapia R, Zumla A, Ippolito G. Viral Hepatitis: Etiology, Epidemiology, Transmission, Diagnostics, Treatment, and Prevention. Infect Dis Clin North Am 2019 Dec;33(4):1045-1062.
2 Progress report on HIV, viral hepatitis and sexually transmitted infections 2019. Accountability for the global health sector strategies, 2016–2021. Geneva: World Health Organization; 2019 (WHO/CDS/HIV/19.7). Licence: CC BY-NC-SA 3.0 IGO.
3 Consolidated strategic information guidelines for viral hepatitis: planning and tracking progress towards elimination. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO.
4 Lanini S, Easterbrook PJ, Zumla A, Ippolito G. Hepatitis C: global epidemiology and strategies for control. Clin Microbiol Infect 2016 Oct;22(10):833-838.
5 Lanini S, Pisapia R, Capobianchi MR, Ippolito G. Global epidemiology of viral hepatitis and national needs for complete control. Expert Rev Anti Infect Ther 2018 Aug;16(8):625-639.
6 Lanini S, Minosse C, Vairo F, et al. A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio, Italy; August 2016 - March 2017. PLoS One 2017 Nov 10;12(11):e0185428.
7 Tosti ME, Alfonsi V, Lacorte E, et al. Acute Hepatitis B After the Implementation of Universal Vaccination in Italy: Results From 22 Years of Surveillance (1993-2014). Clin Infect Dis 2016 Jun 1;62(11):1412-8.
8 Chow EP, Tucker JD, Wong FY, et al. Disparities and risks of sexually transmissible infections among men who have sex with men in China: a meta-analysis and data synthesis. PLoS One 2014 Feb 24;9(2):e89959.
9 Inoue T, Tanaka Y. Hepatitis B virus and its sexually transmitted infection - an update. Microb Cell 2016 Sep 5;3(9):420-437.
10 Nguyen T, Delaugerre C, Valantin MA, et al. Shared HCV Transmission Networks among HIV-1 Positive and Negative Men Having Sex with Men by Ultra-Deep Sequencing. J Acquir Immune Defic Syndr 2019 May 21.
11 Guzzetta G, Minosse C, Pisapia R, Giombini E, Mammone A, Vairo F, Garbuglia AR, Scognamiglio P, Capobianchi MR, Merler S, Ippolito G, Lanini S. Household transmission and disease transmissibility of a large HAV outbreak in Lazio, Italy, 2016-2017. Epidemics. 2019;29:100351.
12 Lazio Regional authority. Programma per la prevenzione delle epatiti [in Italian]. Available at: http://www.regione.lazio.it/binary/rl_sanita/tbl_normativa/SA_DCA_U00331_20_07_2017.pdf
13 WHO position paper on hepatitis A vaccines – June 2012. Wkly Epidemiol Rec 2012 Jul 13;87(28/29):261–76.
14 WHO Hepatitis A vaccination should be part of a comprehensive plan for prevention and control of viral hepatitis. Available at:
https://www.who.int/immunization/newsroom/newsstory_hepa_vaccine_control_viral_hepatitis/en/
15 von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007 Oct 20;370(9596):1453-7.
16 European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017 Aug;67(2):370-398.
17 Mahmood S, Shah KU, Khan TM. Immune Persistence After Infant Hepatitis-B Vaccination: A Systematic Review and Meta-Analysis. Sci Rep. 2018 Aug 8:12550.
18 Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet. 2000 Feb 12;355(9203):561-5.
19 Zhang Z. Model building strategy for logistic regression: purposeful selection. Ann Transl Med 2016 Mar;4(6):111.
20 European Centre for Disease Prevention and Control. Syphilis. In: ECDC. Annual epidemiological report for 2017. Stockholm: ECDC; 2019.
21 European Centre for Disease Prevention and Control. Gonorrhoea. In: ECDC. Annual epidemiological report for 2017. Stockholm: ECDC; 2019.
22 European Monitoring Centre for Drugs and Drug Addiction – Italy 2017. Available at: http://www.emcdda.europa.eu/system/files/publications/4519/TD0616150ENN.pdf
23 Brennan J, Moore K, Sizemore L, et al. Notes from the Field: Acute Hepatitis A Virus Infection Among Previously Vaccinated Persons with HIV Infection - Tennessee, 2018. MMWR Morb Mortal Wkly Rep 2019 Apr 12;68(14):328-329.
24 Ministero della Salute Linee Guida Italiane sull’utilizzo della Terapia Antiretrovirale e la gestione diagnostico-clinica delle persone con infezione da HIV-1. Available at: http://www.salute.gov.it/imgs/C_17_pubblicazioni_2696_allegato.pdf
25 Ministero della Salute Piano Nazionale Prevenzione Vaccinale PNPV 2017-2019. Available at: http://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf
26 Rich AJ, Lachowsky NJ, Cui Z, et al. Event-Level Analysis of Anal Sex Roles and Sex Drug Use Among Gay and Bisexual Men in Vancouver, British Columbia, Canada. Arch Sex Behav 2016 Aug;45(6):1443-51.
27 Persson KI, Tikkanen R, Bergström J, Berglund T, Thorson A, Forsberg BC. Experimentals, bottoms, risk-reducers and clubbers: exploring diverse sexual practice in an Internet-active high-risk behaviour group of men who have sex with men in Sweden. Cult Health Sex 2016;18(6):639-53.
28 Bordi L, Rozera G, Scognamiglio P, et al. Monophyletic outbreak of Hepatitis A involving HIV-infected men who have sex with men, Rome, Italy 2008-2009. J Clin Virol 2012 May;54(1):26-9.
29 Ndumbi P, Freidl GS, Williams CJ, et al. Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area, June 2016 to May 2017. Euro Surveill 2018 Aug;23(33).
30 Mariojoules J, Castro G, Pisano MB, et al. Hepatitis A outbreak affecting men who have sex with men (MSM) in central Argentina, occurred in July 2017-April 2018, later than the European outbreak. J Clin Virol 2019 Aug;117:49-53.
31 Rivas V, Barrera A, Pino K, et al. Hepatitis A outbreak since November 2016 affecting men who have sex with men (MSM) in Chile connected to the current outbreak in MSM in Europe, situation up to October 2017. Euro Surveill 2018 Mar;23(9).
32 Tanaka S, Kishi T, Ishihara A, et al. Outbreak of hepatitis A linked to European outbreaks among men who have sex with men in Osaka, Japan, from March to July 2018. Hepatol Res 2019 Jun;49(6):705-710.
33 Rodríguez-Tajes S, Perpiñán E, Caballol B, et al. Hepatitis A outbreak in Barcelona among men who have sex with men (MSM), January-June 2017: A hospital perspective. Liver Int 2018 Apr;38(4):588-593.
34 Gozlan Y, Bar-Or I, Rakovsky A, et al. Ongoing hepatitis A among men who have sex with men (MSM) linked to outbreaks in Europe in Tel Aviv area, Israel, December 2016 - June 2017. Euro Surveill 2017 Jul 20;22(29).
35 Tosti ME, Alfonsi V, Lacorte E, et al. Acute Hepatitis B After the Implementation of Universal Vaccination in Italy: Results From 22 Years of Surveillance (1993-2014). Clin Infect Dis 2016 Jun 1;62(11):1412-8.
36 Yang S, Tian G, Cui Y, et al. Factors influencing immunologic response to hepatitis B vaccine in adults. Sci Rep 2016 Jun 21;6:27251.
37 Scognamiglio P, Girardi E, Fusco M, et al. Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy. BMC Infect Dis 2009 Jun 7;9:86.
38 Huynh C, Minuk GY, Uhanova J, et al. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada. Vaccine 2017 Aug 16;35(35 Pt B):4515-4522.
39 Chang MH. Breakthrough HBV infection in vaccinated children in Taiwan:surveillance for HBV mutants. Antiviral Ther 2010;15(3 Pt B):463–9.
40 Poovorawan Y, Chongsrisawat V, Theamboonlers A, et al. Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region. J Viral Hepat 2011;18(5):369–75.
41 Borresen ML, Koch A, Biggar RJ, et al. Effectiveness of the targeted hepatitis B vaccination program in Greenland. Am J Publ Health 2012;102(2):277–84.
42 Zhang L, Yan BY, Li MS, et al. Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China. Zhonghua yu fang yi xue za zhi [Chin J Prevent Med] 2013;47(10):933–9.
43 Chotard J, Inskip HM, Hall AJ, et al. The Gambia Hepatitis Intervention Study: follow-up of a cohort of children vaccinated against hepatitis B. J Infect Dis 1992;166(4):764–8.
44 Yuen MF, Lim WL, Chan AO, Wong DK, Sum SS, Lai CL. 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc 2004;2(10):941–5.
45 Hadler SC, Francis DP, Maynard JE, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986 Jul 24;315(4):209-14.
46 Zhang L, Yan B, Lv J, et al. Antibody response to hepatitis B vaccine is independently associated with hepatitis B breakthrough infection among adults: Results from a three-year follow-up study in China. Vaccine 2018 Apr 12;36(16):2207-2212.
47 Poorolajal J, Hooshmand E. Booster dose vaccination for preventing hepatitis B. Cochrane Database Syst Rev 2016 Jun 7;(6):CD008256.
48 Zhao H, Zhou YH. Revaccination against hepatitis B in late teenagers who received vaccination during infancy: Yes or no? Hum Vaccin Immunother 2018 Feb 1;14(2):456-463.
49 Wang Y, Chen T, Lu LL, et al. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults. Vaccine 2017 Feb 15;35(7):1064-1070.
50 Chen YS, Chu CH, Wang JH, Lin JS, Chang YC. Predictors of Booster Response to Hepatitis B Vaccine at 15 years of age: A Cross-Sectional School-Based Study. Pediatr Neonatol 2016 Aug;57(4):302-9.
51 European Centre for Disease Prevention and Control. Public health guidance on screening and vaccination for infectious diseases in newly arrived migrants within the EU/EEA. Stockholm: ECDC; 2018
52 Zhou K, Terrault NA. Gaps in Viral Hepatitis Awareness in the United States in a Population-based Study. Clin Gastroenterol Hepatol 2019 Jun 4. pii: S1542-3565(19)30598-1.
53 European Centre for Disease Prevention and Control. Systematic review on hepatitis B and C prevalence in the EU/EEA. Stockholm: ECDC; 2016.
54 Lanini S, Scognamiglio P, Mecozzi A, et al. Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study. BMC Infect Dis 2018 May 16;18(1):223.
55 Benson AR, Kumar R, Tomkins A. On the Relevance of Irrelevant Alternatives. WWW 2016, April 11–15, 2016, Montréal, Québec, Canada. ACM 978-1-4503-4143-1/16/04.